Latest Biotechnology, Pharmaceutical and Healthcare News

16:39 EDT 6th May 2016 | BioPortfolio

Showing News Articles 1–25 of 500,000+

Friday 6th May 2016

Intarcia Preps FDA Filing for Revolutionary Diabetes Drug

​Intarcia Therapeutics, a Boston-based drug maker worth a whopping $5.5 billion, announced on Friday top-line results for its Phase 3 cardiovascular safety study of its type 2 diabetes treatment.Read more about Intarcia Preps FDA Filing for Revoluti

OvaScience Reports First Quarter 2016 Financial Results

Thursday, May 5th 2016 at 8:00pm UTC — AUGMENT treatment gains traction in growing fertility market and Company expands access internationally — — New research supports AUGMENT and pipeline treatments— WALTHAM, Mass.–(BUSINESS WIRE)– OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, toda...

Third Annual BLINGO Raises $200,000 for CureDuchenne

Friday, May 6th 2016 at 4:19pm UTC CureDuchenne Honors Sarepta Therapeutics for Their Commitment to Duchenne Community PHILADELPHIA–(BUSINESS WIRE)– On Saturday, April 30th, CureDuchenne, a national nonprofit that raises awareness and funds for research to find a cure for Duchenne Muscular Dystrophy, hosted a “blinged-out” event at The Logan Hotel—featuring special bingo callers ...

ACADIA Pharmaceuticals Reports First Quarter 2016 Financial Results

Thursday, May 5th 2016 at 8:05pm UTC SAN DIEGO–(BUSINESS WIRE)– ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders, today announced its unaudited financial results for the first quarter ended March 31, 2016. “We are very exci...

Epizyme Continues to Build Senior Leadership Team with Appointment of Matthew Ros as Chief Operating Officer

Friday, May 6th 2016 at 12:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating novel epigenetic therapies for people with cancer, today announced that it has expanded its senior leadership team with the addition of Matthew Ros, who joins the company as Chief Operating Officer. In this role, Mr. … Cet article...

Owens & Minor Announces Second Quarter 2016 Cash Dividend of $0.255 per Share

Thursday, May 5th 2016 at 10:05pm UTC RICHMOND, Va.–(BUSINESS WIRE)– Owens & Minor, Inc. (NYSE:OMI) today announced that its board of directors has approved the payment of the second-quarter 2016 cash dividend in the amount of $0.255 per share. The cash dividend is payable on June 30, 2016, to shareholders of record as of June … Cet article Owens & Minor Announces Second ...

XenoPort Reports First Quarter Financial Results

Thursday, May 5th 2016 at 8:05pm UTC Doubled HORIZANT net sales year-over-year to $13.7 million, with new prescriptions achieving an all-time high in March Continued to deliver on key corporate objectives SANTA CLARA, Calif.–(BUSINESS WIRE)– XenoPort, Inc. (Nasdaq: XNPT) announced today its financial results for the first quarter ended March 31, 2016. Total revenues for … Cet art...

Cytori ATHENA Trial Results Support Symptomatic Benefit From Cytori Cell Therapy

Friday, May 6th 2016 at 12:39pm UTC SAN DIEGO–(BUSINESS WIRE)– Cytori Therapeutics, Inc. (NASDAQ:CYTX) announced today the presentation of six and twelve month data from the ATHENA Trials at the annual meeting of The Society for Cardiovascular Angiography and Interventions. The ATHENA trials are two prospective, randomized (2:1, active : placebo), double-blind, controlled, parallel gro...

Washington DCs Ultimate Beauty Destination Announces Semi-Annual Shopping Event

The boutique at SHERBER+RAD, Washington DC's ultimate beauty destination will host their semi-annual shopping event on Thursday May 19, 2016 from 5-8pm at their 1101 15th St. NW, Washington, DC location. Washington, DC (PRWEB) May 06, 2016 For the first time anywhere, SHERBER+RAD brings together an uncompromising expert edit of the ultimate in skincare, beauty, and fragrance as chosen by thei...

No longer lost in translation: Biochemists watch gene expression in real time

Credit: Tatsuya Morisaki/Colorado State University May 5, 2016 Source:Colorado State University Summary: Biochemists have made a live-cell movie of RNA translation, the fundamental cellular process by which a ribosome decodes a protein. Sixty years after Francis Crick first described it, these scientists have illuminated, in a single living cell, this […]

3d Printing in Dentistry: Coming of age as a manufacturing technique

SOURCE April 6, 2016 A SET of straight and gleaming teeth makes for a beautiful smile. But how many people who have undergone a little dental maintenance know that they may have inside their mouths some of the first products of a new industrial revolution? Tens of millions of dental […]

MDLIVE Media Advisory: The differences between a cold vs. allergy, and the best way to treat.

The differences between a cold vs. allergy, and the best way to treat from MDLIVE's Dr. Alan Menkes Sunrise, FL (PRWEB) May 06, 2016 WHO: Dr. Alan Menkes from MDLIVE, the nation’s largest telehealth network of doctors, pediatricians and therapists. WHAT: Over 50 million Americans struggle with allergy symptoms each year , including sneezing, stuffy or runny nose,     red...

FDA knocks-back Otsuka's digital pill plans

Wants more data on its combination of Abilify and Proteus sensor and pill

Materialise CEO calls for evidence-based approach to medical 3D printing

  SOURCE May 5, 2016  Fried Vancrean, CEO of leading 3D printing solutions provider Materialise NV, has issued a formal call to establish a unified and standardized approach to measuring the clinical, economical, and patient benefits of medical 3D printing.  Doing so, he argues, will enhance the healthcare industry’s confidence […]

Genomic relationship between autism and bipolar disorder

Genomic relationship between autism and bipolar disorder Larry H. Bernstein, MD, FCAP, Curator LPBI   Autism and Bipolar Disorder Share Common Genetic Roots New study describes genetic commonalities among various psychiatric disorders. [Jonathan Bailey, NHGRI] Complex neurological di...

Lymphocytes and Innate immune response

Lymphocytes and Innate immune response Larry H. Bernstein, MD, FCAP, Curator LPBI   Scientists Shed Light on Key Role of Innate Lymphoid Cells in the Immune Response Researchers at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (N...

NACDS Foundation launches Zika prevention campaign in Puerto Rico

David SalazarThe NACDS Foundation typically focuses on fostering evidence-based research through strategic partnerships and decided to assist in Zika prevention education after discussions with public health authorities read more

NICE Recommends Praluent, Repatha for Treating Cholesterol

NICE has published final draft guidance recommending 2 new treatment options for some people who have conditions that put them at extremely high risk of heart attacks or strokes.

Report: Hair perfume the hottest new trend in fragrance

Gina AcostaFragrance brands are creating hair “perfumes” and “mists” based on their signature scents — and the new products are quickly gaining a cult following with pop culture influencers such as Kylie Jenner, according to the New York Post. (New York Post)

Valeant sets up special committee to oversee pricing

Canada’s Valeant Pharmaceuticals International has formed a new Patient Access and Pricing Committee…

Amgen To Present At The Bank Of America Merrill Lynch 2016 Health Care Conference

THOUSAND OAKS, Calif., May 6, 2016 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch 2016 Health Care Conference at 2:20 p.m. PT on Wednesday, May 11, 2016, in Las Vegas. David W. Meline, executive vice president and chief financial officer at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen'...

Kaiser Foundation Health Plan and Hospitals Report First Quarter 2016 Financial Results

OAKLAND, Calif., May 6, 2016 /PRNewswire/ -- Kaiser Foundation Health Plan, Inc., Kaiser Foundation Hospitals and their respective subsidiaries (KFHP/H) today reported a combined total operating revenue of $16.3 billion for the quarter ending March 31, 2016, compared to $15.0 billion in the same period in 2015. Operating income was $701 million in the first quarter of 2016, compared to $741 m...

Wimbledon Athletics Shatters Previous Records with Unprecedented Week of Student Testing

Significant expansion to new markets primes Wimbledon Health Partners for increasing growth in the on-site diagnostic testing business aimed at preventing sudden cardiac death among young athletes. Boca Raton, FL (PRWEB) May 06, 2016 Wimbledon Health Partners, the industry leader in on-site diagnostic testing for athletic and physician programs, reports a record-breaking week of cardiovascular te...

Long-Term Warfarin Use for AF Linked to Dementia Risk

Patients with the heart rhythm disorder atrial fibrillation (AF) who were treated long term with the blood thinner, warfarin, may have higher rates of dementia, according to a recent study of more than 10,000 patients.Read more

NACDS Foundation Launches Zika Prevention Campaign on Radio, Online in Puerto Rico

Radio messages set to debut on Monday, May 9, and subsequent online placements will encourage women to seek advice from physicians and pharmacists about ways to protect themselves and their unborn children from the effects of Zika. Arlington, Va. (PRWEB) May 06, 2016 The National Association of Chain Drug Stores (NACDS) Foundation today announced a radio- and digital-based Zika education initiati...

Quick Search

BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device information service collates press releases, news articles and blogs from over 275 sources.